Developing Antibody Diagnostics & Therapeutics for Rheumatoid Arthritis
Developing Novel Preclinical Candidates for Cancer

Discovering Novel Antibody-Based Diagnostics and Therapeutics To Address Unmet Medical Needs


Antibody Diagnostics

ModiQuest founders developed the first diagnostics test for rheumatoid arthritis, marketed worldwide and included in the American College of Rheumatology (ACR) diagnostics criteria.

Read more >>

Antibody Therapeutics

ModiQuest's pipeline of preclinical candidates includes monoclonal and recombinant antibody therapeutics for prevention and treatment of established rheumatoid arthritis.

Read more >>

About ModiQuest

Experts in monoclonal and recombinant antibody generation for autoimmune and oncology, with high throughput hybridoma and phage display technology.

Read more >>